| Long name: |
ELL Primary Polyclonal Antibody |
| Also known as: |
ELL PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
ELL |
| Specificity: |
This is a highly specific antibody against ELL |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human ELL |
| Gene ID number: |
8178 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
ELL (11-19 lysine-rich leukemia protein), ELL is abundantly expressed in peripheral blood leukocytes, Elongation is thought to be a critical stage for the regulation of gene expression, It is also thought to regulate cellular proliferation, MLL (myeloid/lymphoid leukemia, The gene encoding human ELL, This is a multistep process, also designated ALL-1 and HRX) regulates embryonal and hematopoietic development, also designated MEN, brain, called the transcription cycle, clearance, elongation and termination, functions as an RNA polymerase II elongation factor that increases the rate of transcription by suppressing transient pausing by RNA polymerase II, heart, is one of several genes that undergo translocation with the MLL gene on chromosome 11q23 in acute myeloid leukemia, kidney, liver and ovary, lung, placenta and testis, promoter, skeletal muscle, that includes five stages: preinitiation, thymus, which maps to chromosome 19p13, with lower expression in spleen, 1, Eukaryotic RNA polymerase II mediates the synthesis of mature and functional messenger RNA |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
ELL1, Eleven nineteen lysine rich leukemia gene, Eleven-nineteen lysine-rich leukemia protein, Men, RNA polymerase II elongation factor, RNA polymerase II elongation factor ELL, elongation factor RNA polymerase II, ELL_HUMAN |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
ELL |
| Short name: |
ELL Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
ELL (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
23114 |
| Gene: |
ELL |
More about : ELL |
| Long gene name: |
elongation factor for RNA polymerase II |
| Synonyms gene: |
C19orf17 |
| Synonyms gene name: |
chromosome 19 open reading frame 17 elongation factor RNA polymerase II |
| Synonyms: |
Men ELL1 PPP1R68 |
| Synonyms name: |
protein phosphatase 1, regulatory subunit 68 eleven-nineteen lysine-rich leukemia gene |
| Locus: |
19p13, 11 |
| Discovery year: |
2003-09-17 |
| GenBank acession: |
U16282 |
| Entrez gene record: |
8178 |
| Pubmed identfication: |
7991593 8596958 |
| RefSeq identity: |
NM_006532 |
| Classification: |
Protein phosphatase 1 regulatory subunits Super elongation complex |
| Havana BLAST/BLAT: |
OTTHUMG00000183364 |